US · Healthcare · Medical Devices
EPS came in at -0.16 against a street estimate of -0.12 — a miss of 33.3%.
Analysts rate Alphatec Holdings Inc a buy (9 buy, 1 hold, 0 sell out of 10) with an average price target of $15.79.
| Fund | Stake |
|---|---|
| BlackRock Inc | 6.53% |
| American Century Companies Inc | 4.22% |
| Vanguard Capital Management, LLC | 3.18% |
| Royal Bank of Canada | 2.92% |
| BNP Paribas Investment Partners SA | 2.34% |
| State Street Corp | 1.96% |
| Geode Capital Management, LLC | 1.88% |
| Nuveen, LLC | 1.84% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 ALPHATEC HOLDINGS, INC. – 10-Q SUMMARY (Q2 2026) --- HEADLINE NUMBERS • Revenue (6M 2026): $405.6 million vs. $354.7 million (6M 2025) — up 14.3% • | 2026-08-04 |
| Results announced · Q3 2026 ALPHATEC HOLDINGS Q2 2026 FINANCIAL RESULTS HEADLINE NUMBERS • Q2 2026 Total Revenue: $214 million – Up 15% year-over-year • Surgical Revenue: $196 | 2026-08-04 |
| Board / officer change · Q2 2026 ALPHATEC HOLDINGS, INC. - 8-K SUMMARY HEADLINE NUMBERS • Record date: April 15, 2026 • Total issued and outstanding shares: 153,702,057 • Shares rep | 2026-06-11 |
| Quarterly report · Q1 2026 ALPHATEC HOLDINGS, INC. — Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Revenue: $192.1 million (Q1 2026) vs. $169.2 million (Q1 2025) — up 13.6% • Gross | 2026-05-05 |
| Results announced · Q2 2026 ALPHATEC HOLDINGS, INC. (ATEC) – Q1 2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Total revenue: $192 million, up 14% year-over-year • Surgical revenue: | 2026-05-05 |
| Proxy statement · Q2 2026 ALPHATEC HOLDINGS, INC. – PROXY STATEMENT SUMMARY CEO COMPENSATION • Patrick S. Miles (CEO, President, Chairman) total compensation: Not fully speci | 2026-04-29 |
| Board / officer change · Q1 2026 ALPHATEC HOLDINGS, INC. - 8-K SUMMARY HEADLINE NUMBERS • No financial metrics disclosed in this filing • Board size reduced from 8 to 7 directors as | 2026-03-03 |
| Annual report FY2025 ALPHATEC HOLDINGS, INC. – 10-K SUMMARY HEADLINE NUMBERS • Total revenue for 2025: $764.2 million – up $152.6 million or 25% compared to $611.6 milli | 2026-02-24 |
Readable in the app.
| Announcement | Date |
|---|---|
| Q2 results beat; full-year revenue outlook reaffirmed, EBITDA guidance raised Alphatec Holdings (ATEC), a spine surgery device company, reported strong second quarter 2026 results. Total revenue reached $214 million, up 15% year-over-year, with surgical revenue of $19 | 2026-08-04 |
| Full-year 2026 total revenue expected to approximate $890 million Alphatec Holdings (ATEC), a spine surgery solutions company, reported strong 2025 results with 25% revenue growth to $764 million and announced 2026 guidance of $890 million (17% growth). Ke | 2026-02-24 |
| 2025 revenue grew 25% to $764M; 2026 outlook provided at $890M Alphatec Holdings (ATEC), a spine surgery solutions company, announced strong 2025 preliminary results and provided optimistic 2026 guidance. Key highlights: 2025 total revenue grew 25% to a | 2026-01-12 |
| Full-year revenue and profitability guidance raised Alphatec Holdings (ATEC), a spine surgery solutions company, reported strong Q3 2025 results and raised full-year guidance. Key highlights: Total revenue grew 30% to $197 million, with surgi | 2025-10-30 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Alphatec Holdings Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.